Literature DB >> 23814116

Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.

Xin Bi1, Xuewei Zhu, MyNgan Duong, Elena Y Boudyguina, Martha D Wilson, Abraham K Gebre, John S Parks.   

Abstract

OBJECTIVE: Hepatic ATP binding cassette transporter A1 (ABCA1) expression is critical for maintaining plasma high-density lipoprotein (HDL) concentrations, but its role in macrophage reverse cholesterol transport and atherosclerosis is not fully understood. We investigated atherosclerosis development and reverse cholesterol transport in hepatocyte-specific ABCA1 knockout (HSKO) mice in the low-density lipoprotein (LDL) receptor KO (LDLrKO) C57BL/6 background. APPROACH AND
RESULTS: Male and female LDLrKO and HSKO/LDLrKO mice were switched from chow at 8 weeks of age to an atherogenic diet (10% palm oil, 0.2% cholesterol) for 16 weeks. Chow-fed HSKO/LDLrKO mice had HDL concentrations 10% to 20% of LDLrKO mice, but similar very low-density lipoprotein and LDL concentrations. Surprisingly, HSKO/LDLrKO mice fed the atherogenic diet had significantly lower (40% to 60%) very low-density lipoprotein, LDL, and HDL concentrations (50%) compared with LDLrKO mice. Aortic surface lesion area and cholesterol content were similar for both genotypes of mice, but aortic root intimal area was significantly lower (20% to 40%) in HSKO/LDLrKO mice. Although macrophage (3)H-cholesterol efflux to apoB lipoprotein-depleted plasma was 24% lower for atherogenic diet-fed HSKO/LDLrKO versus LDLrKO mice, variation in percentage efflux among individual mice was <2-fold compared with a 10-fold variation in plasma HDL concentrations, suggesting that HDL levels, per se, were not the primary determinant of plasma efflux capacity. In vivo reverse cholesterol transport, resident peritoneal macrophage sterol content, biliary lipid composition, and fecal cholesterol mass were similar between both genotypes of mice.
CONCLUSIONS: The markedly reduced plasma HDL pool in HSKO/LDLrKO mice is sufficient to maintain macrophage reverse cholesterol transport, which, along with reduced plasma very low-density lipoprotein and LDL concentrations, prevented the expected increase in atherosclerosis.

Entities:  

Keywords:  atherosclerosis; cardiovascular diseases; cholesterol; lipids; lipoproteins

Mesh:

Substances:

Year:  2013        PMID: 23814116      PMCID: PMC3793209          DOI: 10.1161/ATVBAHA.112.301110

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  55 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.

Authors:  R K Tangirala; E M Rubin; W Palinski
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

4.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.

Authors:  S Rust; M Rosier; H Funke; J Real; Z Amoura; J C Piette; J F Deleuze; H B Brewer; N Duverger; P Denèfle; G Assmann
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

5.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

Review 6.  New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Authors:  Gary F Lewis; Daniel J Rader
Journal:  Circ Res       Date:  2005-06-24       Impact factor: 17.367

7.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts.

Authors:  T P Carr; C J Andresen; L L Rudel
Journal:  Clin Biochem       Date:  1993-02       Impact factor: 3.281

10.  Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice.

Authors:  L L Rudel; K Kelley; J K Sawyer; R Shah; M D Wilson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-11       Impact factor: 8.311

View more
  20 in total

Review 1.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

2.  Genetic and hormonal control of hepatic steatosis in female and male mice.

Authors:  Frode Norheim; Simon T Hui; Emre Kulahcioglu; Margarete Mehrabian; Rita M Cantor; Calvin Pan; Brian W Parks; Aldons J Lusis
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

Review 3.  microRNAs and HDL life cycle.

Authors:  Alberto Canfrán-Duque; Cristina M Ramírez; Leigh Goedeke; Chin-Sheng Lin; Carlos Fernández-Hernando
Journal:  Cardiovasc Res       Date:  2014-06-03       Impact factor: 10.787

Review 4.  Cholesterol and lipoprotein metabolism: Early Career Committee contribution.

Authors:  Hanrui Zhang; Ryan E Temel; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

5.  Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.

Authors:  Mingxia Liu; Jeremy Allegood; Xuewei Zhu; Jeongmin Seo; Abraham K Gebre; Elena Boudyguina; Dongmei Cheng; Chia-Chi Chuang; Gregory S Shelness; Sarah Spiegel; John S Parks
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

6.  [Bidirectional regulation of Pam3CSK4?induced inflammatory response by ATP?binding cassette transporter A1 knockdown in mouse mononuclear macrophages in vitro].

Authors:  Yue Li; Xi Lan; Li-Tao Wu; Xiao-Juan DU; Kombo Osoro Ezra; Dong-Min Li; She-Min Lu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

7.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

8.  Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis.

Authors:  Chia-Chi C Key; Mingxia Liu; C Lisa Kurtz; Soonkyu Chung; Elena Boudyguina; Timothy A Dinh; Alexander Bashore; Peter E Phelan; Barry I Freedman; Timothy F Osborne; Xuewei Zhu; Lijun Ma; Praveen Sethupathy; Sudha B Biddinger; John S Parks
Journal:  Cell Rep       Date:  2017-06-06       Impact factor: 9.423

9.  Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.

Authors:  Alexander C Bashore; Mingxia Liu; Chia-Chi C Key; Elena Boudyguina; Xianfeng Wang; Caitlin M Carroll; Janet K Sawyer; Adam E Mullick; Richard G Lee; Shannon L Macauley; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06-06       Impact factor: 8.311

10.  ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation.

Authors:  Alexis Stamatikos; Nagadhara Dronadula; Philip Ng; Donna Palmer; Ethan Knight; Bradley K Wacker; Chongren Tang; Francis Kim; David A Dichek
Journal:  Hum Gene Ther       Date:  2018-10-02       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.